Aillis Inc.

Aillis specializes in the development of testing methods for Influenza using artificial intelligence technology.

Based based in Asia-Pacific (APAC), Aillis Inc. works in medtech, founded in 2017.

Profile

"Aillis is a Medtech company specializing in the development of AI-based testing methods for Influenza diagnosis. Aillis focuses on creating AI-powered medical devices for hospitals and healthcare professionals to replicate the diagnostic skills and expertise of experienced physicians. By harnessing the power of AI technology, Aillis aims to revolutionize healthcare by enabling consistent and accurate medical assessments across various healthcare settings. Their flagship product is an AI medical device that analyzes throat images to diagnose Influenza. Aillis plans to expand its range of targeted diseases using accumulated data, paving the way for new business opportunities in the medical field. Through their innovative approach to medical diagnostics, Aillis is at the forefront of leveraging artificial intelligence to enhance disease detection and improve patient outcomes."

The company sits in the medtech segment, where it competes on its core product or service.

The company is recorded as being based in Asia-Pacific (APAC).

It is recorded at the Series_Unknown stage.

The company reports a headcount in the c_00011_00050 range.

It has disclosed roughly $1.3B in funding.

Website: aillis.jp